Evidence map›Paper›PMID 36848557›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Mfsd2a utilizes a flippase mechanism to mediate omega-3 fatty acid lysolipid transport.

Geok-Lin Chua, Bryan C Tan, Randy Y J Loke, Menglan He, Cheen-Fei Chin, Bernice H Wong, Alvin C Y Kuk, Mei Ding, Markus R Wenk, Lan Guan and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Structure and allostery in major facilitator superfamily symport mechanisms.Acta crystallographica. Section D, Structural biology · 2026
    Article
  6. Review
  7. Mfsd2a is important for maintaining epidermal homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Allosteric effects of the coupling cation in melibiose transporter MelB.bioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Molecular basis of Spns1-mediated lysophospholipid transport from the lysosome.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Geok-Lin ChuaSignature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.ORCID 0000-0002-9763-0652
Bryan C TanSignature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.ORCID 0000-0001-6399-8814
Randy Y J LokeSignature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.ORCID 0000-0003-0819-3479
Menglan HeSignature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.ORCID 0000-0002-5375-9454
Cheen-Fei ChinSignature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.ORCID 0000-0001-6753-9228
Bernice H WongSignature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.ORCID 0000-0001-8981-1376
Alvin C Y KukSignature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.ORCID 0000-0002-4122-0259
Mei DingSingapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, Singapore 117456, Singapore.ORCID 0000-0003-3920-568X
Markus R WenkSingapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, Singapore 117456, Singapore.
Lan GuanDepartment of Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430.ORCID 0000-0002-2274-361X
Federico TortaSingapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, Singapore 117456, Singapore.ORCID 0000-0001-7545-7484
David L SilverSignature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.ORCID 0000-0002-7289-9890

Funding

Integrated approaches to symport mechanisms of membrane transportersR01GM122759 · NIGMS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI GUAN, LAN · 2018 to 2021
$1.4M
Human Frontiers Science Program LT000733/2020-LMinistry of Education, Singapore MOE2019-T2-1-031Ministry of Education, Singapore MOE-T2EP30220-0001Ministry of Health, Singapore MOH-000217National Research Foundation Singapore (NRF) NRF-NRFI2017-05NIGMS NIH HHS R01 GM122759
6 · The paper itself

Abstract

Major Facilitator Superfamily Domain containing 2a (Mfsd2a) is a sodium-dependent lysophosphatidylcholine (LPC) transporter expressed at the blood-brain barrier that constitutes the main pathway by which the brain obtains omega-3 fatty acids, such as docosahexanoic acid. Mfsd2a deficiency in humans results in severe microcephaly, underscoring the importance of LPC transport by Mfsd2a for brain development. Biochemical studies and recent cryo-electron microscopy (cryo-EM) structures of Mfsd2a bound to LPC suggest that Mfsd2a transports LPC via an alternating access mechanism between outward-facing and inward-facing conformational states in which the LPC inverts during transport between the outer and inner leaflet of a membrane. However, direct biochemical evidence of flippase activity by Mfsd2a has not been demonstrated and it is not understood how Mfsd2a could invert LPC between the outer and inner leaflet of the membrane in a sodium-dependent manner. Here, we established a unique in vitro assay using recombinant Mfsd2a reconstituted in liposomes that exploits the ability of Mfsd2a to transport lysophosphatidylserine (LPS) coupled with a small molecule LPS binding fluorophore that allowed for monitoring of directional flipping of the LPS headgroup from the outer to the inner liposome membrane. Using this assay, we demonstrate that Mfsd2a flips LPS from the outer to the inner leaflet of a membrane bilayer in a sodium-dependent manner. Furthermore, using cryo-EM structures as guides together with mutagenesis and a cell-based transport assay, we identify amino acid residues important for Mfsd2a activity that likely constitute substrate interaction domains. These studies provide direct biochemical evidence that Mfsd2a functions as a lysolipid flippase.

Indexed as

Fatty Acids, Omega-3SymportersAmino AcidsCryoelectron MicroscopyHumansLipopolysaccharidesLiposomesLysophosphatidylcholinesAmino AcidsFatty Acids, Omega-3LipopolysaccharidesLiposomesLysophosphatidylcholinesMFSD2A protein, humanSymportersblood–brain barrierflippasemembraneMfsd2atransporter

Identifiers

PMID36848557
PMCPMC10013850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.